Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Apr;30(2):171-173.
doi: 10.3350/cmh.2024.0078. Epub 2024 Feb 2.

Steatotic liver disease: Know your enemies

Lung-Yi Mak  1   2
Affiliations
Editorial

Steatotic liver disease: Know your enemies

Lung-Yi Mak. Clin Mol Hepatol. 2024 Apr.
No abstract available

Keywords: Cardiovascular diseases; Cohort effect; Fatty liver; Hepatocellular carcinoma; Malignancy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The authors have no conflicts to disclose.

Figures

Figure 1.
Figure 1.
Accountability of NAFLD diagnostic method in heterogeneous clinical presentation and prognosis among NAFLD patients. NAFLD, non-alcoholic fatty liver disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; NITs, non-invasive tests; NASH, non-alcoholic steatohepatitis; HCC, hepatocellular carcinoma.
See this image and copyright information in PMC

Comment on

References

    1. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84. - PubMed
    1. Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542–1556. - PubMed
    1. Song SJ, Lai JC, Wong GL, Wong VW, Yip TC. Can we use old NAFLD data under the new MASLD definition? J Hepatol. 2024;80:e54–e56. - PubMed
    1. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015;13:643–654.e1-9. quiz e39-40. - PMC - PubMed
    1. Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129:375–378. - PubMed

MeSH terms